Table 1. Clinical characteristics of the enrolled patients.
| mean ± SD | range | |
|---|---|---|
| Age (year) | 69.3 ± 9.5 | 37–83 |
| BMI (kg/m2) | 25.1 ± 3.8 | 19.9–34.4 |
| Systolic blood pressure (mmHg) | 133 ± 18 | 92–170 |
| Diastolic blood pressure (mmHg) | 78 ± 10 | 60–103 |
| Fasting blood sugar (mg/dL) | 111 ± 26 | 77–202 |
| IRI (µU/mL) | 8.5 ± 5.5 | 1.6–23.2 |
| HOMA–R | 2.3 ± 1.6 | 0.42–7.5 |
| HbA1c (NGSP) (%) | 6.5 ± 0.8 | 5.2–8.5 |
| Total cholesterol (mg/dL) | 175 ± 35 | 109–267 |
| Triglyceride (mg/dL) | 127 ± 61 | 50–361 |
| HDL–C (mg/dL) | 42.3 ± 9.4 | 26–68 |
| LDL–C (mg/dL) | 108 ± 32 | 50–200 |
| hsCRP (mg/dL) | 0.21 ± 0.29 | 0.01–1.16 |
| serum creatinine (mg/dL) | 0.89 ± 0.22 | 0.48–1.40 |
| eGFR (mL/min/1.73 m2) | 70.6 ± 20.9 | 38.2–127.9 |
| CysC (mg/L) | 1.14 ± 0.30 | 0.63–1.77 |
| APN (µg/mL) | 9.9 ± 5.0 | 3.5–28.1 |
Data are expressed as mean ± standard deviation (SD).
IRI: immunoreactive insulin, hsCRP: high-sensitive C-reactive protein.